Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:BLUSF

BELLUS Health (BLUSF) Stock Price, News & Analysis

BELLUS Health logo

About BELLUS Health Stock (OTCMKTS:BLUSF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$6.46
$14.51
52-Week Range
N/A
Volume
3.45 million shs
Average Volume
39,610 shs
Market Capitalization
$2.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Receive BLUSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLUSF Stock News Headlines

Trying The Natural Blush Trick
Was $49. Now $7. (not for long)
It was $49 to join our Money Monday Revolution… …a renegade group of traders defying the odds, and targeting a year’s worth of gains with just one trade every Monday at 9:30am… But right now, for a limited time… You can get access for just $7 today!
See More Headlines

BLUSF Stock Analysis - Frequently Asked Questions

BELLUS Health Inc (OTCMKTS:BLUSF) released its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.01. The company had revenue of $0.01 million for the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%.

Company Calendar

Last Earnings
5/08/2019
Today
5/24/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BLUSF
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,010,000.00
Net Margins
-49,910.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30,000.00
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.35 billion
Optionable
Not Optionable
Beta
1.55

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:BLUSF) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners